PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast
391 episodes - English - Latest episode: about 1 month ago - ★★★★★ - 3 ratingsPeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Farnaz Dadmanesh, MD - Increasing Importance of HER2 and HER3 Testing in the Context of an Expanding Targeted Therapies Landscape for Breast, Gastrointestinal, Lung, and Other Cancers: Latest Updates and Practical Guidance for Pathologists
May 11, 2020 23:00 - 1 hour VideoGo online to PeerView.com/SMP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In the evolving era of precision cancer care, increasing emphasis is placed on detecting molecular alterations driving the development of specific cancers and targeting them with matched therapies or combinations that can yield the best outcomes for patients. Such is the case with HER2—and, more recently, also HER3 and TROP2—which are gaining growing interest a...
Christian T. Ruff, MD, MPH - Making the Connection: A Call to Action Against Undiagnosed Atrial Fibrillation—Improving Detection, Reducing Risk
May 08, 2020 23:00 - 35 minutes VideoGo online to PeerView.com/NTH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in cardiology discusses best practices for the screening, diagnosis, and treatment of atrial fibrillation to reduce thromboembolic risk. Upon completion of this activity, participants will be able to: Recognize the prevalence of undiagnosed atrial fibrillation (AF) in patients 65 years and older at risk for AF and stroke, Discuss the...
Harry P. Erba, MD, PhD/James M. Foran, MD, FRCPC - The Continuing Wave of Innovation in AML: Getting the Most From the Convergence of Novel Therapy and Allogeneic Transplant
April 20, 2020 23:00 - 50 minutes VideoGo online to PeerView.com/WRR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The recent wave of therapeutic innovation in the management of patients with acute myeloid leukemia (AML) has had implications for many different patient populations, including those who are eligible for allogeneic hematopoietic stem cell transplantation (HCT). Most evidence currently supports a management model that includes the use of newer cytotoxic formulat...
Mitchell S. Cairo, MD - Following the Trail of Evidence in VOD Management: How Modern Risk Assessment, Diagnostic Principles, and Treatment Are Improving Care
April 17, 2020 23:00 - 52 minutes VideoGo online to PeerView.com/DYW860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In PeerView’s latest CME-certified onDemand activity, based on a symposium at the 2020 Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR, experts lead a series of evidence-based “MasterClass” scientific discussions exploring the nuances of VOD risk assessment, diagnosis, and treatment. The experts also share their perspectives on several a...
Michael E. Wechsler, MD - The Evolving Landscape of Severe Asthma Management: Selecting Patients for Novel Treatment and Improving Adherence
April 15, 2020 23:00 - 1 hour VideoGo online to PeerView.com/MYK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts on severe asthma discuss how to identify and diagnose patients with this condition and how novel treatments are improving patient outcomes. A patient joins the discussion to share his unique experience with severe asthma and how biologic therapy has improved his quality of life. Upon completion of this activity, participants should be ...
Praveen Akuthota, MD - Overcoming Challenges Associated With the Diagnosis and Management of EGPA: An Exploration of Novel Approaches
March 06, 2020 23:00 - 47 minutes VideoGo online to PeerView.com/SGN860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an eosinophilic granulomatosis with polyangiitis (EGPA) expert offers expert insight to help physicians achieve a greater understanding into the recognition, diagnosis, and management of EGPA, including the latest clinical evidence with respect to novel and emerging therapies. Upon completion of this activity, participants should be better abl...
Jerry Vockley, MD, PhD - Novel Strategies and Emerging Evidence to Address Unmet Needs in Treating Patients With Long-Chain Fatty Acid Oxidation Disorders
March 04, 2020 23:00 - 30 minutes VideoGo online to PeerView.com/QXV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in medical genetics and inborn metabolism errors discusses novel strategies and emerging evidence for the identification and management of patients with long-chain fatty acid oxidation disorders. Upon completion of this activity, participants should be better able to: Recognize the signs and symptoms associated with the clinical pres...
Steven B. Deitelzweig, MD, MMM, SFHM, FACP, FACC - Demystifying the Real-World Evidence in Atrial Fibrillation: A Comparative Look at the Direct Oral Anticoagulants for Reducing the Risk of Stroke Among Patients With Nonvalvular Atrial Fibrillation
February 28, 2020 23:00 - 29 minutes VideoGo online to PeerView.com/NNV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in hospital and vascular medicine discusses how real-world data enhance the data from randomized clinical trials on direct oral anticoagulants (DOACs) for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) and offers insight on applying evidence from both real-world studies and randomized clinical trials to imp...
John P. Leonard, MD - Realizing the Promise of Novel Therapeutics in NHL: A MasterClass and Tumor Board on Clinical Decision-Making in FL, MCL, and DLBCL
February 26, 2020 23:00 - 1 hour VideoGo online to PeerView.com/CQB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity based on a recent live symposium preceding the 61st ASH Annual Meeting and Exposition, experts in non-Hodgkin lymphoma present a series of “tumor board”–style case discussions and scientific lectures focused on key issues in the selection and use of newer therapeutics—including BTK, PI3K, and BCL-2 inhibitors; IMiDs; antibodies; and CAR T thera...
Andre H. Goy, MD - How I Think, How I Treat: BTK Inhibitors as a Clinical Strategy in CLL, MCL, and Beyond—Therapeutic Selection, Sequencing, and Next Steps
February 17, 2020 23:00 - 1 hour VideoGo online to PeerView.com/FKM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. First- and second-generation Bruton tyrosine kinase (BTK) inhibitors have transformed the therapeutic landscape of several lymphoid cancers, including chronic lymphocytic leukemia (CLL), and mantle cell lymphoma (MCL). The present and future management of these diseases will increasingly be defined by the integration of BTK inhibitors—along with other novel the...
Joseph K. Han, MD - Driven by Type 2 Inflammation: The Potential of Novel Biologic Therapies in Managing Chronic Rhinosinusitis With Nasal Polyps
January 22, 2020 23:00 - 23 minutes VideoGo online to PeerView.com/QJM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this infographic-based activity, an expert in chronic rhinosinusitis with nasal polyps (CRSwNP) discusses how to diagnose and differentiate this condition from other phenotypes of CRS. Novel agents for the treatment of CRSwNP are also explored, as well as how to incorporate these new therapies into treatment plans. Upon completion of this activity, participa...
Reynold A. Panettieri, Jr., MD - Improving Outcomes in Uncontrolled Moderate-to-Severe Asthma: Choosing the Right Treatment for the Right Patient
January 20, 2020 23:00 - 39 minutes VideoGo online to PeerView.com/EPJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an asthma expert discusses advances in the understanding of the pathogenesis of asthma and novel targeted treatments that have been developed as a result. Strategies for identifying uncontrolled moderate-to-severe asthma patients who would benefit from these agents and clinical data for the currently available and emerging biologic therapies f...
Mikhail Kosiborod, MD, FACC, FAHA - Reducing Cardiovascular Risks in Patients With Type 2 Diabetes: Identifying Your Role on the Diabetes Management Team
January 10, 2020 23:00 - 1 hour VideoGo online to PeerView.com/YNQ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. This PeerView onDemand activity, based on an educational session from the 2019 Scientific Sessions of the American Heart Association in Philadelphia, Pennsylvania, features a panel of cardiology, endocrinology, and primary care experts, who provide their clinical perspectives on assessing patients with type 2 diabetes mellitus (T2DM) who are at high risk for ca...
George L. Bakris, MD, FASN, FAHA - Recent Advances in the Management of Hyperkalemia: The Role of Newer Treatment Strategies to Improve Patient Outcomes
January 06, 2020 23:00 - 35 minutes VideoGo online to PeerView.com/YPD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in cardiology discusses the risk factors and symptoms associated with hyperkalemia and provides strategies to identify and manage these patients as well as methods for incorporating newer treatment options based on the latest evidence. Upon completion of this activity, participants should be better able to: Recognize the risk factors...
Lorinda Chung, MD, MS - Recognizing and Managing Progressive Fibrosing ILD in Patients With Connective Tissue Diseases: Examining the Potential Clinical Implications of Antifibrotic Therapy
January 03, 2020 23:00 - 1 hour VideoGo online to PeerView.com/ZBA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in interstitial lung disease discuss the latest clinical evidence for the use of antifibrotic therapy for ILDs. Upon completion of this activity, participants should be better able to: Recognize the prevalence and risk of interstitial lung disease (ILD) in patients with connective tissue diseases (CTDs), including systemic sclerosis (S...
Nicola A. Hanania, MD, MS - Living With Severe Asthma: Understanding the Patient Experience to Guide Therapeutic Decision-Making
December 30, 2019 23:00 - 1 hour VideoGo online to PeerView.com/AZE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Approximately 20% of patients with asthma have uncontrolled, moderate to severe disease with recurrent exacerbations and persistent symptoms despite maximized standard-of-care controller therapy. Many of these patients have substantially reduced lung function and continue to lose lung function over time. About 50% of those with asthma have type 2 (T2) inflammat...
Carlos E. Bueso-Ramos, MD, PhD & Naval Daver, MD - Pathology Insights on Innovation in AML The Rapid Emergence of Precision Diagnostics & Novel Therapy Across the Spectrum of Care
December 23, 2019 23:00 - 59 minutes VideoGo online to PeerView.com/YCF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a live symposium held in conjunction with the 2019 ASCP Annual Meeting in Phoenix, Arizona, pathology and hematology-oncology experts offer guidance on how to differentiate high-risk AML subtypes at diagnosis, determine useful prognostic features, and use the results of diagnostic testing to help guide the integration of newly validat...
Javed Butler, MD, MPH, MBA - Early Recognition and Management of Chronic Heart Failure in the Primary Care Setting
December 18, 2019 23:00 - 42 minutes VideoGo online to PeerView.com/RNV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in heart failure discusses the early diagnosis and management of CHF. Upon completion of this activity, participants should be better able to: Implement evidence-based guidelines for early recognition and diagnosis of CHF, Apply available CHF therapies based on ACC/AHA/HFSA guidelines and clinical efficacy and safety data, Employ str...
William J. Calhoun, MD, and Neil S. Skolnik, MD - Teaming Up to Overcome Challenges in Severe Asthma Management: The Role of Targeted Therapy in Personalized Care
December 16, 2019 23:00 - 58 minutes VideoGo online to PeerView.com/FWN860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in pulmonology discuss strategies for overcoming challenges in the management of severe asthma and the role of targeted therapies in personalized care. Upon completion of this activity, participants should be better able to: Explain the role of inflammatory mediators and mechanisms in the pathogenesis of severe asthma and in the contex...
Matthew T. Ballo, MD, FACR - Readying the Modern Radiation Oncology Practice for Incorporation of a Fourth Modality in Cancer Treatment: Understanding the Science, Evidence & Clinical Application Across a Range of Solid Malignancies
December 13, 2019 23:00 - 1 hour VideoGo online to PeerView.com/APQ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. While much of cancer therapy development focuses on systemic drugs and the mitigation of associated adverse events, new avenues utilizing innovative multimodal solutions have demonstrated the benefit of efficacy with minimal toxicity in solid tumors. New treatment modalities such as tumor treating fields (TTFields) and innovative combination strategies have eme...
Ian W. Flinn, MD, PhD - Innovative Therapy for B-Cell Malignancies: A MasterClass and Tumor Board on Decision-Making in CLL, FL, and MCL
December 11, 2019 23:00 - 1 hour VideoGo online to PeerView.com/RZK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. PeerView’s latest MasterClass and “Tumor Board” on demand activity is based on a live symposium at the 2019 hematologic malignancies meeting in Chicago and covers the ongoing integration of novel and next-generation therapeutics in the management of several B-cell malignancies, including follicular lymphoma (FL), chronic lymphocytic leukemia (CLL), and mantle c...
Sarah Luisa Melendez, MD and Doris Quon, MD, PhD - Recognizing and Managing Hemophilia in the Emergency Department in an Era of Expanding Therapeutic Options: A Progress-in-Practice MasterClass and Practicum
December 09, 2019 23:00 - 1 hour VideoGo online to PeerView.com/CSQ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in hemophilia discuss the latest advances in the treatment of hemophilia and the importance of shared decision-making in optimizing the management of patients with hemophilia who present to the ED. Upon completion of this activity, participants should be better able to: Apply current data on the efficacy, safety, and tolerability of ap...
Fernando J. Martinez, MD, MS - Winning Strategies for Diagnosing and Managing Chronic Obstructive Pulmonary Disease
December 04, 2019 23:00 - 45 minutes VideoGo online to PeerView.com/YAX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Optimal management of chronic obstructive pulmonary disease (COPD) begins with accurate diagnosis and ongoing, appropriate assessment of disease severity. The burden of COPD, and its associated morbidity and mortality, are not always recognized, and underdiagnosis remains prevalent. A personalized, evidence-based approach to the management of patients with COPD...
Kathryn Beal, MD, and Sandip Patel, MD - Challenges, Controversies, and Opportunities in the Management of EGFR-Mutant Lung Cancer With Central Nervous System Metastases: Working Together to Improve Patient Outcomes
November 11, 2019 23:00 - 1 hour VideoGo online to PeerView.com/PPF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Central nervous system (CNS) metastases occur commonly in patients with lung cancer, and those patients with epidermal growth factor receptor (EGFR)-mutant non–small cell lung cancer (NSCLC) are particularly prone to their development. Treatment of brain metastases is challenging, and there are varied perspectives among different specialists about the best appr...
Lynette M. Sholl, MD - A Pan-Cancer, Pan-Biomarker Exploration of the Opportunities to Realize the Potential of Precision Immuno-Oncology: Are Pathology Professionals Ready for the Challenge?
November 08, 2019 23:00 - 1 hour VideoGo online to PeerView.com/UJT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Cancer immunotherapies are demonstrating remarkable clinical activity in an increasing number of malignancies, and as the immunotherapy arsenal has continued to expand, it has become clear that reliable biomarkers are needed to guide clinical decisions regarding treatment selection and identification of patients who are most likely to benefit from specific agen...
Sorayah Bourenane, MSN, RN, CNL / Marianne Davies, DNP, ACNP, AOCNP - Identification, Triage, and Management of Immune-Related Adverse Effects in Patients With Cancer Presenting to the Emergency Department: Practical Guidance for Emergency Nurses
November 06, 2019 23:00 - 47 minutes VideoGo online to PeerView.com/AMF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Treatment of cancer has been transformed by the new immune checkpoint inhibitor class of agents that have shown remarkable benefit in many different types of tumors, but they can also cause unusual immune-related adverse effects (irAEs) that can affect any organ system. Expanding use of these immunotherapies in oncology means that emergency medicine professiona...
Roy H. Decker, MD, PhD - NSCLC Tumor Board: Navigating the Evolving Role of Immunotherapy in Multimodal Management of Locally Advanced and Early-Stage Lung Cancer
November 04, 2019 23:00 - 1 hour VideoGo online to PeerView.com/YKQ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, oncology experts discuss the role of immunotherapy in multimodal management of locally advanced and early-stage lung cancer. Upon completion of this activity, participants should be better able to: Discuss how to harness the immune system in the treatment of cancer, mechanisms of action of immune checkpoint inhibitors, and rationale for use of...
John B. Buse, MD, PhD - Exploring the Science and Practice of GLP-1 Receptor Agonists: An Update on Current and Emerging Evidence
October 30, 2019 23:00 - 1 hour VideoGo online to PeerView.com/YYH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in endocrinology discusses the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in the treatment of patients with diabetes. Upon completion of this activity, participants should be better able to: Apply current guidelines for the use of GLP-1 RAs in appropriately selected patients with T2DM, Differentiate current and emer...
Andrew F. Shorr, MD, MPH, MBA, FACP, FCCP - Improving the Diagnosis, Treatment, and Outcomes of Patients With HAP and VAP: A Critical Look at Current Guidelines and New Treatment Options
October 25, 2019 23:00 - 37 minutes VideoGo online to PeerView.com/GBE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in pulmonary and critical care medicine discusses the microbiology, diagnosis, and treatment of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). Upon completion of this activity, participants will be able to: List the pathogens commonly implicated in causing hospital-acquired pneumonia (HAP) and ventilator...
Michael E. Wechsler, MD - Relieving the Burden of EGPA: Examining the Latest Advances in Diagnosis and Treatment
September 30, 2019 23:00 - 35 minutes VideoGo online to PeerView.com/ZJH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in eosinophilic granulomatosis with polyangiitis (EGPA) discuss the pathophysiology and diagnosis of EGPA, as well as strategies for treatment and the impact on patient quality of life. A patient also joins the discussion to provide unique perspectives on living with EGPA and interacting with healthcare providers. Upon completion of th...
Vanita R. Aroda, MD - Putting Basal Insulin Therapy to Work for Patients With Type 2 Diabetes Mellitus
September 27, 2019 23:00 - 53 minutes VideoGo online to PeerView.com/HMF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert endocrinologist discusses the use of basal insulin therapy to manage patients with type 2 diabetes mellitus (T2DM), focusing on identifying patients who should receive insulin, overcoming common barriers to insulin use, navigating the currently approved basal insulins, and providing evidence-based guidance for insulin titration. Upon...
Stephen A. Strickland, MD, MSCI - The Oncology Team and Secondary AML: Conversations on New Science and Its Effect on Patient Care
September 25, 2019 23:00 - 31 minutes VideoGo online to PeerView.com/ZVS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, a hematologist/oncologist and a nurse professional discuss the characteristics and management of secondary AML, with an emphasis on practical aspects of care and the use of novel therapy. This multidisciplinary panel also features commentary from a patient with secondary AML and discusses the patient’s experience of a secondary AML diagnosis a...
Paul W. Noble, MD - A Visual Guide to Timely and Accurate Diagnosis of Idiopathic Pulmonary Fibrosis
September 11, 2019 23:00 - 27 minutes VideoGo online to PeerView.com/AWA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this infographic-based activity, an expert in idiopathic pulmonary fibrosis (IPF) discusses key characteristics of high-resolution computed tomography (HRCT) patterns that differentiate usual interstitial pneumonia (UIP) from probable UIP, indeterminate for UIP, and non-IPF; how to decide whether a patient should undergo a lung biopsy; and implementa...
James R. Gavin III, MD, PhD - Swimming in Cloudy Water: Using the Latest Guidelines to Clear Up Clinical Confusion About T2DM Management
September 04, 2019 23:00 - 1 hour VideoGo online to PeerView.com/ASM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in primary care, endocrinology, and diabetes education offer insights on providing patient-centered diabetes care and developing individualized treatment plans for patients with type 2 diabetes mellitus (T2DM). Upon completion of this activity, participants should be better able to: Reconcile recommendations offered in evidence...
Robert Z. Orlowski, MD, PhD - Driving Change in Multiple Myeloma: Updates on Novel Agent Classes and Next-Generation Therapeutics
August 14, 2019 23:00 - 50 minutes VideoGo online to PeerView.com/TXD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in the management of MM discusses the implications of recent efficacy and safety data that support the ongoing integration and use of several innovative treatments, such as antibody-based therapies, next-generation IMiDs and proteasome inhibitors, and novel therapies directed against intracellular targets. The expert also pro...
Amy L. Olson, MD, MSPH - Applying New Insights to Improve Diagnosis and Management of Interstitial Lung Diseases
August 12, 2019 23:00 - 34 minutes VideoGo online to PeerView.com/JGG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in interstitial lung diseases offers new insights for improving the diagnosis and management of ILD. Upon completion of this activity, participants will be able to: Outline the prevalence, burden of illness, and signs and symptoms of interstitial lung disease (ILD), including IPF and SSc-ILD, Employ updated guidelines and bes...
Benjamin Levy, MD - Candid Conversations About NSCLC—Live From Chicago: Navigating Immunotherapies and Combinations in the Search for the Best Strategy for Each Patient
August 09, 2019 23:00 - 1 hour VideoGo online to PeerView.com/WED860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Non–small cell lung cancer (NSCLC) is one of the tumor types where the novel class of cancer immunotherapies—the immune checkpoint inhibitors—has had the biggest impact and certainly become a major component of the treatment arsenal in the advanced disease setting. While the approval and availability of an increasing number and variety of immunotherapeu...
Charles B. Simone, II, MD, FACRO - Expanding Treatment Choices in Mesothelioma: Exploring the Promise of Tumor Treating Fields and Novel Systemic Approaches to Optimize Patient Outcomes
August 07, 2019 23:00 - 39 minutes VideoGo online to PeerView.com/VGX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in malignant pleural mesothelioma discuss tumor treating fields and novel systemic approaches to optimize patient outcomes. Upon completion of this activity, participants will be able to: Describe the rationale for use of tumor treating fields (TTFields), antiangiogenic strategies, and immunotherapeutic approaches in the manage...
Michael E. Wechsler, MD - Advances in the Treatment of Uncontrolled Persistent Asthma: Expert Insights in Personalizing Patient Care
August 05, 2019 23:00 - 43 minutes VideoGo online to PeerView.com/PBN860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in asthma discuss recent advances in the treatment of uncontrolled persistent asthma and offer practical guidance on personalizing patient care. Upon completion of this activity, participants should be better able to: Describe the mechanisms of inflammatory pathways in uncontrolled persistent asthma and their implications for t...
John Allan, MD - Taking a New Look at Mantle Cell Lymphoma in the Era of Novel Agent Classes: From Innovative Concepts to Practical Applications of Evidence
July 31, 2019 23:00 - 21 minutes VideoGo online to PeerView.com/TVG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in oncology reviews recent evidence for novel therapeutics for the management of mantle cell lymphoma and offers practical insight on integrating clinical evidence into patient care and management, including for patients who have progressed after upfront therapy and who are candidates for second-line treatment. Upon completio...
Marilyn K. Glassberg, MD - Systemic Sclerosis–Associated Interstitial Lung Disease: Expert Insights on Early Diagnosis and Optimal Management
July 26, 2019 23:00 - 58 minutes VideoGo online to PeerView.com/UBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Systemic sclerosis (SSc) is a rare, often fatal, connective tissue disease that affects multiple organ systems. Early diagnosis, and thus earlier treatment, is critical to prevent disease progression, with its irreversible fibrosis and organ damage. In particular, regular monitoring for lung involvement, especially interstitial lung disease (ILD), is vi...
Nathan H. Fowler, MD - A MasterClass on Innovative Therapy in B-Cell Lymphoma: Evidence, Clinical Guidance, and Insights on the Future of Patient Care
July 24, 2019 23:00 - 1 hour VideoGo online to PeerView.com/GQC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Novel therapeutic drug classes have transformed the management of several B-cell lymphoma subtypes, including chronic lymphocytic leukemia, follicular lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma. The arrival of BTK and PI3K inhibitors, next-generation antibodies, immunomodulators, BCL-2 inhibitors, CAR T cell therapy, and other str...
Monica Kraft, MD - The Latest Evidence on Treatment for Uncontrolled Persistent Asthma: Breaking News From Dallas
July 22, 2019 23:00 - 28 minutes VideoGo online to PeerView.com/GSV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an asthma expert discusses the latest evidence and data on treatment for persistent asthma presented at the American Thoracic Society Conference 2019 in Dallas, Texas. Upon completion of this activity, participants should be better able to: Discuss the latest clinical data for the efficacy and safety of approved and emerging treatments...
Professor Claire Harrison - Changing the Treatment Story in Myelofibrosis: New Science and More Choices for Challenging Cases in the JAK Inhibitor Era
July 17, 2019 23:00 - 1 hour VideoGo online to PeerView.com/SCG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The emergence of JAK inhibitor therapy for the management of myelofibrosis has offered clinicians effective targeted therapy options that can be used in different patient populations to improve outcomes and ameliorate the debilitating symptoms of myelofibrosis. As additional JAK inhibitors near regulatory approval, several therapeutic questions have eme...
The Emergence of Oral Therapy as a Pillar of Care in B-Cell Lymphoma: Insights and Expert Opinions From the Hematology-Oncology Team
July 15, 2019 23:00 - 1 hour VideoGo online to PeerView.com/AWT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, hematology and oncology experts discuss the emergence of novel, orally administered therapeutics as management options for patients with B-cell lymphoma. This activity also features the perspectives of a patient with small lymphocytic lymphoma and his experience of oral therapy during the course of his therapeutic journey. Upon complet...
Robert D. McBane, II, MD - Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?
July 12, 2019 23:00 - 30 minutes VideoGo online to PeerView.com/TGQ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in venous thromboembolism (VTE) reviews the latest clinical science and guidelines pertaining to cancer-associated VTE prophylaxis and treatment. This video-based program also focuses on strategies to help learners prepare for the practical integration of direct oral anticoagulants (DOACs) in cancer-associated VTE and illustr...
Evan J. Lipson, MD - Beyond the Basics of Immuno-Oncology: Navigating Clinical Challenges to Maximize the Benefits and Minimize the Risks of Cancer Immunotherapies
July 10, 2019 23:00 - 33 minutes VideoGo online to PeerView.com/JHZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in the use of immunotherapies for cancer discuss the expanding role of immunotherapy in oncology, focusing on current and emerging strategies, immune-mediated adverse reactions, and best practices for their identification and management, as well as the use of immunotherapy in more challenging patient populations. Upon completio...
Doreen Addrizzo-Harris, MD - Advances in the Management of Nontuberculous Mycobacterial Lung Disease (NTM-LD): Expert Insights From Dallas
July 08, 2019 23:00 - 29 minutes VideoGo online to PeerView.com/FBD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in nontuberculous mycobacterial lung disease reviews the latest efficacy and safety data presented at the 2019 American Thoracic Society International Conference and offers insight on individualizing treatment plans for patients with nontuberculous mycobacterial lung disease (NTM-LD). Upon completion of this activity, partici...
John B. Buse, MD, PhD - An Update on SGLT2 Inhibition for the Prevention and Treatment of Kidney Disease in Patients With Type 2 Diabetes
July 05, 2019 23:00 - 40 minutes VideoGo online to PeerView.com/XRN860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in endocrinology discusses the clinical potential of SGLT2 inhibitors for the prevention and treatment of kidney disease in patients with type 2 diabetes. Upon completion of this activity, participants should be better able to: Review the proposed mechanism(s) that support the clinical potential of SGLT2 inhibitors to provide...
Jessica Donington, MD - The Expanding Role of Immunotherapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Thoracic Surgeons
July 03, 2019 23:00 - 1 hour VideoGo online to PeerView.com/CPZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. New evidence from clinical trials assessing immunotherapies and combinations in lung cancer is emerging at a rapid pace. As a result, the treatment landscape is constantly evolving, and checkpoint inhibitor–based therapeutic approaches are establishing a foothold not only in advanced disease but in earlier stages of lung cancer as well. Immunotherapy ha...